Evidence map›Paper›PMID 30061859›Full record

ArticleFrontiers in neurology2018

Salivary IL-1ß as an Objective Measure for Fatigue in Multiple Sclerosis?

Katrin Hanken, Carina Sander, Lara Qaiser, Hans-Peter Schlake, Andreas Kastrup, Michael Haupts, Paul Eling, Helmut Hildebrandt

Open access · goldAbstract read
In one paragraph

Article in Frontiers in neurology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Katrin HankenKlinikum Bremen-Ost, Department of Neurology, Bremen, Germany.
Carina SanderDepartment of Psychology, Carl von Ossietzky Universität Oldenburg, Oldenburg, Germany.
Lara QaiserDepartment of Psychology, Carl von Ossietzky Universität Oldenburg, Oldenburg, Germany.
Hans-Peter SchlakeRehabilitationszentrum Oldenburg GmbH, Oldenburg, Germany.
Andreas KastrupKlinikum Bremen-Ost, Department of Neurology, Bremen, Germany.
Michael HauptsAugustahospital Anholt, Clinic for Neurology, Anholt, Germany.
Paul ElingDonders Institute for Brain, Cognition and Behaviour, Radboud University Nijmegen, Nijmegen, Netherlands.
Helmut HildebrandtKlinikum Bremen-Ost, Department of Neurology, Bremen, Germany.
Carl von Ossietzky Universität Oldenburg · DEKlinikum Bremen-Mitte · DEHeinrich Heine University Düsseldorf · DEKlinikum Oldenburg · DERadboud University Nijmegen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

disease coursefatigueIL-1ßinflammationmultiple sclerosisproinflammatory cytokines

Identifiers

PMID30061859
PMCPMC6055002
OpenAlexW2883871083

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.